Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-medicated G2-M arrest

Cited 0 time in scopus
Metadata Downloads
Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-medicated G2-M arrest
M S Park; H D Chae; J H Yun; M S Jung; Y S Kim; S H Kim; Moon Hi Han; Deug Young Shin
Bibliographic Citation
Cancer Research, vol. 60, no. 3, pp. 542-545
Publication Year
Recent studies have suggested that p53 regulates the G2 checkpoint in the cell cycle and that this function is required for the maintenance of genomic integrity. In this study, we investigated a regulatory role of p53 specifically in G2-M transition. Human bladder carcinoma cells lacking functional p53 were synchronized at G1-S, which is preceded by p53-mediated G1 arrest. p53 expression in the synchronized cells was induced by infection with a recombinant adenovirus that encodes p53. After release from the G1-S arrest, the cells progressed to S-phase and G2 but failed to enter mitosis. Biochemical analysis showed that p53 inhibits cell cycle-dependent expression of cdc2 and cyclin B1 and consequently inhibits cdc2 kinase. The role of cyclin B1-associated cdc2 kinase in p53-mediated G2-M arrest was further investigated by expression of both cyclin B1 and cdc2AF, in which inhibitory phosphorylation sites were substituted. The cells expressing both cdc2AF and cyclin B1 showed a constitutive activation of cdc2 kinase during cell cycle progression and passed through G2-M regardless of p53 expression. Therefore, inactivation of cdc2 kinase through cdc2 and cyclin B1 repression is an essential step in p53-mediated G2-M arrest.
cyclin B1enzyme activationcyclin Benzyme activation
Amer Assoc Cancer Research
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.